* Core Laboratories NV CLB.N CLB is expected to show a
rise in
quarterly revenue when it reports results on October 26.
* The Amstelveen Noord-holland-based company is expected to
report a 6.6% increase in revenue to $125.818 million from
$117.99 million a year ago, according to the mean estimate from
5 analysts, based on Refinitiv data. The company's guidance on
July 27 2022, for the period ended September 30, was for revenue
between $123.00 million and $129.00 million.
* Refinitiv's mean analyst estimate for Core Laboratories
NV is
for earnings of 15 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.
* Wall Street's median 12-month price target for Core
Laboratories
NV is $20, above its last closing price of $19.44.
The company's guidance on July 27 2022 for the period ended
September 30 was for Earnings before Interest and Taxes between
USD10.1 million and USD13.3 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.12 0.14 0.12 Missed -12
Mar. 31 2022 0.07 0.09 0.08 Missed -11.6
Dec. 31 2021 0.20 0.20 0.20 Met -0.4
Sep. 30 2021 0.18 0.19 0.18 Missed -3.8
Jun. 0.19 0.19 0.18 Missed -6.2
30 2021
Mar. 31 2021 0.12 0.13 0.15 Beat 15
Dec. 31 2020 0.15 0.15 0.18 Beat 16.5
Sep. 30 2020 0.13 0.15 0.16 Beat 9.2
This summary was machine generated October 24 at 21:31 GMT. All
figures in US dollars unless otherwise stated